[HTML][HTML] Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
MR Aghanoori, DR Smith, S Shariati-Ievari… - Molecular …, 2019 - Elsevier
Objective Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
MR Aghanoori, DR Smith… - Molecular …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
MR Aghanoori, DR Smith, S Shariati-Ievari, A Ajisebutu… - 2019 - escholarship.org
ObjectiveDiabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
[PDF][PDF] Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
MR Aghanoori, DR Smith, S Shariati-Ievari, A Ajisebutu… - 2018 - researchgate.net
Objective: Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
[HTML][HTML] Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
MR Aghanoori, DR Smith, S Shariati-Ievari… - Molecular …, 2019 - ncbi.nlm.nih.gov
Objective Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
[PDF][PDF] Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
MR Aghanoori, DR Smith, S Shariati-Ievari, A Ajisebutu… - 2018 - scienceopen.com
Objective: Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
MR Aghanoori, DR Smith, S Shariati-Ievari… - Molecular …, 2018 - europepmc.org
Objective Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
MR Aghanoori, DR Smith, S Shariati-Ievari… - Molecular …, 2018 - europepmc.org
Objective Diabetic sensorimotor polyneuropathy (DSPN) affects approximately half of
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …
diabetic patients leading to significant morbidity. There is impaired neurotrophic growth …